Agreement between cerebrospinal fluid biomarkers, brain 18-Fluorodeoxyglucose PET, and clinical diagnosis in older adults with cognitive impairment

Background: Clinical practice has advanced toward a combined diagnostic approach that involves clinical criteria and biological markers for Alzheimer’s disease (AD) and other dementias. Objective: To establish the level of diagnostic agreement between an initial clinical diagnosis and cerebrospinal...

Descripció completa

Dades bibliogràfiques

Autors principals:	Alberto J. Mimenza-Alvarado, Karen G. León-del-Ángel, Rodrigo Hernández-Ramírez, Juan de D. Rodríguez-Callejas, Sara G. Yeverino-Castro, Sara G. Aguilar-Navarro
Format:	Artigo
Idioma:	Inglês
Publicat:	Permanyer 2024-01-01
Col·lecció:	Revista de Investigación Clínica
Matèries:	18F-Fluorodeoxyglucose-positron emission tomography. Cerebrospinal fluid. Cognitive impairment. Dementia. Alzheimer’s disease. Brain aging.
Accés en línia:	https://www.clinicalandtranslationalinvestigation.com/frame_esp.php?id=513
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!